menu
    • menu

    Company profile for Epizyme

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Epizyme’s vision is to rewrite therapy for cancer and other serious diseases through targeted epigenetic medicines. We aspire to change the standard of care for patients and physicians by developing medicines with fundamentally new mechanisms of action. We are focused on creating medicines that are targeted at specific causes of diseases, that are orally administered, tolerable, easy to take, and that are based on a deep und...
    Epizyme’s vision is to rewrite therapy for cancer and other serious diseases through targeted epigenetic medicines. We aspire to change the standard of care for patients and physicians by developing medicines with fundamentally new mechanisms of action. We are focused on creating medicines that are targeted at specific causes of diseases, that are orally administered, tolerable, easy to take, and that are based on a deep understanding of the patients that will benefit from them. We are focused on creating medicines that are targeted at specific causes of diseases, that are orally administered, tolerable, easy to take.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EpizymeUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Technology Square, 4th Floor Cambridge, MA 02139
    Telephone
    Telephone
    (617) 229-5872
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.epizyme.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/epizyme
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/epizymerx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    A peak at Pfizer's EZH2 inhibitor flashes hope for some
    A peak at Pfizer's EZH2 inhibitor flashes hope for some

    11 Sep 2022

    // Max Bayer FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/esmo-its-early-days-pfizers-ezh2-inhibitor-theres-glimpse-promise-some

    Max Bayer FIERCEBIOTECH
    11 Sep 2022
    Share Share
    Ipsen completes acquisition of Epizyme expanding its portfolio in oncology
    Ipsen completes acquisition of Epizyme expanding its portfolio in oncology

    13 Aug 2022

    // PRESS RELEASE

    https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-epizyme-expanding-its-portfolio-in-oncology/

    PRESS RELEASE
    13 Aug 2022
    Share Share
    Epizyme Reports Second Quarter 2022 Financial Results
    Epizyme Reports Second Quarter 2022 Financial Results

    09 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220809005463/en

    BUSINESSWIRE
    09 Aug 2022
    Share Share
    Ipsen Extends Expiration Date of Tender Offer for Epizyme
    Ipsen Extends Expiration Date of Tender Offer for Epizyme

    04 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220804006066/en

    BUSINESSWIRE
    04 Aug 2022
    Share Share
    Dire straits detailed for Epizyme before buyout by Ipsen
    Dire straits detailed for Epizyme before buyout by Ipsen

    13 Jul 2022

    // Kevin Dunleavy FIERCEPHARMA

    https://www.fiercepharma.com/pharma/sec-filing-epizyme-details-its-desperate-days-free-fall-ipsen-deal

    Kevin Dunleavy FIERCEPHARMA
    13 Jul 2022
    Share Share
    Ipsen snaps up Epizyme and cancer drug Tazverik for $247M
    Ipsen snaps up Epizyme and cancer drug Tazverik for $247M

    28 Jun 2022

    // Kevin Deunleavy FIERCEPHARMA

    https://www.fiercepharma.com/pharma/still-wheeling-and-dealing-ipsen-acquires-epizyme-and-lymphoma-drug-tazverik-247-million

    Kevin Deunleavy FIERCEPHARMA
    28 Jun 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search